-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EQT+r3gltaLI+4E7MeDYjn9/hp2FXgRXDMcNFs606S/BHsBWRDyyGe2QsindiyfY
 YfdXRZARSHTzmG48JD4rpA==

<SEC-DOCUMENT>0000950152-03-006004.txt : 20030609
<SEC-HEADER>0000950152-03-006004.hdr.sgml : 20030609
<ACCEPTANCE-DATETIME>20030609120308
ACCESSION NUMBER:		0000950152-03-006004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030606
ITEM INFORMATION:		Bankruptcy or receivership
FILED AS OF DATE:		20030609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SHEFFIELD PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		03736942

	BUSINESS ADDRESS:	
		STREET 1:		425 WOODSMILL RD
		CITY:			ST LOUIS
		STATE:			MO
		ZIP:			63017
		BUSINESS PHONE:		3145799899

	MAIL ADDRESS:	
		STREET 1:		425 WOODSMILL RD
		CITY:			ST LOUIS
		STATE:			MO
		ZIP:			63017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19940606
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>l01347ae8vk.txt
<DESCRIPTION>SHEFFIELD PHARMACEUTICALS     8-K
<TEXT>
<PAGE>
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 Current report
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported): JUNE 6, 2003


                         SHEFFIELD PHARMACEUTICALS, INC.
             (Exact name of registrant as specified in its charter)


                                    DELAWARE
                 (State or other jurisdiction of incorporation)


           1-12584                                       13-3808303
   (Commission File Number)                (I.R.S. Employer Identification No.)


3136 WINTON ROAD, SUITE 201, ROCHESTER, NEW YORK              14623
(Address of principal executive offices)                    (Zip Code)


                                 (585) 292-0310
                (Company's telephone number, including area code)


                                (NOT APPLICABLE)
          (Former name or former address, if changed since last report)

================================================================================




<PAGE>




ITEM 3.  BANKRUPTCY OR RECEIVERSHIP

On June 6, 2003, Sheffield Pharmaceuticals, Inc. announced that it has ceased
operations and filed a bankruptcy petition under Chapter 7 of the United States
Bankruptcy Code. The petition was filed on June 6, 2003 with the United States
Bankruptcy Court for the Western District of New York.

As a result of the initiation of bankruptcy proceedings, Sheffield
Pharmaceuticals, Inc. expects that it will cease filing periodic reports under
the Securities Exchange Act of 1934.


<PAGE>





                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                    SHEFFIELD PHARMACEUTICALS, INC.

June 6, 2003                        By:  /s/ Thomas M. Fitzgerald
                                    -----------------------------------------
                                    Thomas M. Fitzgerald
                                    President and Chief Executive Officer

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
